Literature DB >> 1848236

Characterization of the activity of purified recombinant human 5-lipoxygenase in the absence and presence of leukocyte factors.

D Denis1, J P Falgueyret, D Riendeau, M Abramovitz.   

Abstract

Purified recombinant human 5-lipoxygenase was used to investigate the catalytic properties of the protein in the presence and absence of leukocyte stimulatory factors. Recombinant human 5-lipoxygenase was purified to apparent homogeneity (95-99%) from a high expression baculovirus system by chromatography on ATP-agarose with a yield of 0.6 mg of protein per 100 ml of culture (2 x 10(8) cells) and a specific activity of 3-6 mumol of 5-hydroperoxyeicosatetraenoic acid (5-HPETE) per mg of protein in the presence of ATP, Ca2+, and phosphatidylcholine as the only factors. In the absence of leukocyte factors, the reaction catalyzed by the purified recombinant enzyme showed a half-time of maximal 5-HPETE formation of 0.5-0.7 min and was sensitive to the selective 5-lipoxygenase inhibitors BW755C (IC50 = 13 microM) and L-656,224 (IC50 = 0.8 microM). The reaction products of arachidonic acid oxidation were 5-HPETE and 6-trans- and 12-epi-6-trans-leukotriene B4, the nonenzymatic hydrolysis products of leukotriene A4 (LTA4), indicating that the purified protein expressed both the 5-oxygenase and leukotriene A4 synthase activities (ratio 6:1). The microsomal fraction and the 60-90% ammonium sulfate precipitate fraction from sonicated human leukocytes did not increase product formation by the isolated enzyme when assayed in the presence of ATP, Ca2+, and phosphatidylcholine. These factors were found to stabilize 5-lipoxygenase during preincubation of the enzyme at 37 degrees C with the assay mixture but they failed to stimulate enzymatic activity when added at the end of the preincubation period. The results demonstrate that human 5-lipoxygenase can be isolated in a catalytically active form and that protein factors from leukocytes protect against enzyme inactivation but are not essential for enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848236

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Downstream processing of insect cell cultures.

Authors:  A R Bernard; M Lusti-Narasimhan; K M Radford; R S Hale; E Sebille; P Graber
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Physiochemical characterization of ATP binding to human 5-lipoxygenase.

Authors:  M Noguchi; M Miyano; T Matsumoto
Journal:  Lipids       Date:  1996-04       Impact factor: 1.880

3.  Analysis of a nucleotide-binding site of 5-lipoxygenase by affinity labelling: binding characteristics and amino acid sequences.

Authors:  Y Y Zhang; T Hammarberg; O Radmark; B Samuelsson; C F Ng; C D Funk; J Loscalzo
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

4.  Mutagenesis of some conserved residues in human 5-lipoxygenase: effects on enzyme activity.

Authors:  Y Y Zhang; O Rådmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

5.  Therapeutic effect of 28-homobrassinolide on leukotriene synthesis in leukemia cells.

Authors:  Chuan He; Zhigang Liu; Jingcao Huang; Ting Liu
Journal:  Cytotechnology       Date:  2017-11-03       Impact factor: 2.058

6.  Expression of 5-lipoxygenase in differentiating human skin keratinocytes.

Authors:  U Janssen-Timmen; P J Vickers; U Wittig; W D Lehmann; H J Stark; N E Fusenig; T Rosenbach; O Rådmark; B Samuelsson; A J Habenicht
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

7.  The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.

Authors:  K Petrich; P Ludwig; H Kühn; T Schewe
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.